Nucs AI sponsored ProsTIC 2026 in Melbourne, the Peter MacCallum Cancer Centre's global theranostics meeting, held under the theme "Case by Case Theranostics." At Booth 7, our team gave live demonstrations of our AI-powered tools for PSMA-PET/CT imaging, including DeepPSMA for automated tumor detection and whole-body tumor burden quantification, SelectPSMA for treatment response prediction, and TrackPSMA for standardized lesion-level response assessment.

Across the meeting, we met nuclear medicine physicians, physicists, researchers, and industry partners from around the world, and explored how AI can support faster, more confident treatment decisions in prostate cancer theranostics.

We are following up with the partners, collaborators, and institutions we met in Melbourne. If you would like to continue the conversation, book a meeting through the "Contact Us" button above.

‍